This study investigated cerebral glucose metabolism in very early Alzheimer's disease, before a clinical diagnosis of probable Alzheimer's disease is possible, using [ ' 8 F ] f l u~r~d e~x y g l u c~~e positron emission tomography. First, 66 patients with probable Alzheimer's disease with a spectrum of dementia severity were recruited and studied. Cortical metabolic activity was analyzed topographically using three-dimensional stereotactic surface projections. Regression analysis was performed for each brain pixel to predict metabolic patterns of very early disease. Predictions were tested prospectively in a group of 8 patients who complained only of memory impairment without general cognitive decline (Mini-Mental State Examination score, 25 Ifr 1) at the time of scanning but whose condition later progressed to probable Alzheimer's disease. Both results were compared to cerebral metabolic activity in 22 age-similar normal control subjects. Prediction and analysis of actual patients consistently indicated marked metabolic reduction (21-22%) in the posterior cingulate cortex and cinguloparietal transitional area in patients with very early Alzheimer's disease. Mean metabolic reduction in the posterior cingulate cortex was significantly greater than that in the lateral neocortices or parahippocampal cortex. The result suggests a functional importance for the posterior cingulate cortex in impairment of learning and memory, which is a feature of very early Alzheimer's disease. 1997;42:85-94 Energy metabolic abnormalities in the brain of patients with Alzheimer's disease have been investigated using in vivo imaging techniques such as positron emission tomography (PET). Earlier PET reports indicated focal accentuation of metabolic reduction in the parietal and temporal cerebral cortices in addition to general global decline [1][2][3][4][5]. In contrast to the association cortices, energy metabolism in the primary cortices and subcor-,tical structures is preserved relatively when compared to that in the parietotemporal and frontal association cortices. Such structures include the primary sensorimotor and visual cortices, striatum, thalamus, cerebellum, and pons [2, 61. Although these findings may not be specific to Alzheimer's dementia [7, 81, the stereotypical feature of parietotemporal metabolic reduction is recognized consistently and is of potential utility in the clinical diagnosis of Alzheimer's disease [9, 101. In addition to neocortical abnormalities in Alzheimet's disease, recent topographical analysis of PET images found significant metabolic reduction in the posterior cingulate cortex in patients with probable Alzheimer's disease [ 1 11, of comparable severity as that in the parietotemporal association cortex. Metabolic reduction in the posterior cingulate cortex coincides with the observation of severe neurodegeneration in moderate to severe Alzheimer's disease reported in early literature [12]. The metabolic abnormality in the posterior cingulate cortex has been previously overlooked in imaging analysis and was reported only occasionally [ 1 31. This seems to be in part due to the difficulty to appreciate exactly the posterior cingulate cortex on twodimensional tomographic slices oriented parallel to the conventional orbitomeatal plane.
In this study, we investigated the topographical distribution of cerebral energy metabolic alterations in Alzheimer's disease, particularly at a very early stage.
We examined cerebral metabolic PET data sets obtained from two different populations with Alzheimer's disease. First, we predicted a metabolic pattern of a very early stage of the disease using regression analysis of cerebral metabolism and mental status test results i n probable Alzheimer's disease patients with dementia of various severities. Second, we confirmed the predicted result in actual patients with very early Alzheimer's disease whose diagnosis was established later i n a clinical follow-up or at autopsy.
Materials and Methods Subjects
Sixty-six patients with probable Alzheimer's disease were recruited from the Department of Neurology Cognitive Disorders Clinic at The University of Michigan Medical Center hetween 1989 and 1994. The recruitment was part of an ongoing, cross-sectional study of Alzheimer's disease and intended to involve a spectrum of dementia severity. The clinical diagnosis of probable Alzheimer's disease was based on National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria [IS] . The mean age of this group was 68 ? 7.3 (mean -C standard deviation), and the range from 50 to 82 years. Thirty-one men and 35 women were included. Seventeen patients were confirmed to be postmenopausal by medical chart review. Two patients were on estrogen replacement prior to or immediately after the scan data were obtained. At the time of PET scanning, the mean severity of general cognitive decline measured as a Mini-Mental State Examination (MMSE) score [ 191 was 15 t-6.0, ranging from 0 to 23. The clinical dementia rating (CDR) [20] was 0.5 (questionable) in 5 patients, 1 (mild) in 39 patients, 2 (moderate) in 14 patients, and 3 (severe) in 8 patients.
Twenty-three patients who complained of only memory impairment without general cognitive decline were recruited from the same clinic and partially by advertising between 1989 and 1993. All patients underwent thorough neuropsychological testing that revealed quantified, objective evidence of memory impairment with no apparent loss in general cognitive, behavioral, or functional status. The classification of memory impairment required normal mental status (MMSE scores 2 24, CDR = 0.5) with memory performance falling one standard deviation below the normal reference, that is, a combination score of Wechsler Memory Scale (WMS) subtests IV (Logical Memory) and VII (Paired Associates Learning) of 19 or less [21] , andlor a score on the Benton Visual Retention Test of 6 or lower [22] . Each patient underwent PET a t the time of the initial evaluation and was followed clinically for at least 2 years. Eight of 23 patients satisfied the diagnostic criteria of probable Alzheimer's disease during the follow-up period. The interval between the collection of scan data and the diagnosis of probable Alzheimer's disease averaged 23 months, ranging from 4 to 39 months. These patients included 5 men and 3 women with an average age of 69 2 4.6 years and a range from 63 to 73 years. All women were postmenopausal, and 1 patient was on estrogen replacement prior to or immediately after the scanning. At the time of PET, the mean MMSE score \vas 25 ? 1.1, which declined to 20 t-3.0 during the follow-up period. Despite a mild decline in general mental status, severe learning and memory impairment was evident in these 8 patients at the time of PET. For example, of a possible score of 23 on WMS subtest IV, patients scored 3.5 t 1.5 on immediate recall and only 0.17 2 0.25 on 30-minute delayed recall. One patient died approximately 5 years after the initial evaluation, and neuropathological examination including silver, myelin, glial, and ubiquitin stains confirmed Alzheimer's disease pathology without coexistent disorders. In the following sections, these patients are referred to as having "very early Alzheimer's disease." Twenty-two age-similar normal control subjects were recruited by advertising. This group included 7 men and 15 women with an average age of 64 I 7.5 years and a range from 52 to 76. The mean MMSE score was 28 2 1.0, ranging from 26 to 30. The CDR was 0 in all subject-s.
Cerebral Glucose Metabolic Measurement
Each patient underwent cerebral metabolic measurement using PET. PET image analysis was performed by fully automated methods, thus minimizing subjective bias and variability. Each image set was realigned to the bicomniissure stereotactic coordinate system [23] . The difference in an individual's brain size was removed by linear scaling, and regional anatomical differences were minimized by a nonlinear warping technique [24] . As a result, each brain was standardized anatomically to match with a standard atlas brain [23] while preserving regional metabolic activity. Subsequently, maximum cortical activity was extracted to adjacent predefined surface pixels on a pixel-by-pixel basis using a threedimensional stereotactic surface projection technique (3D-SSP) [ 101. This cortical data extraction technique compensates for small anatomical differences in gray matter structures (such as variable depth of gyri) across patients and minimizes a partial volume of the white matter. Approximately 16,000 predefined surface pixels covered the entire cortex, including the medial aspect of the two hemispheres. The extracted data on cortical activity were used in the following analyses.
Data Analysis
Data sets were normalized to the pontine activity prior to further analyses, as energy metabolic activity in the pons is relatively preserved in Alzheimer's disease [6] . Normalization not only enables data analysis of image sets without absolute quantification but also reduces global metabolic variation across subjects, and thus increases sensitivity of the analysis.
Prior to data analysis, gender differences in metabolic activity were examined in 66 patients with probable Alzheimer's disease. The mean ages of the men and women were 67 i 8 and 69 i 7 years, respectively. The mean ages at onset in the men and women were 64 ? 9 and 65 2 7 years, respectively. The mean disease durations in the men and women were 3.9 f 3.0 and 3.8 2 2.5 years, respectively. The mean MMSE scores were 15 i 6 and 15 i 6, respectively. The mean CDRs were 1.3 i 0.7 and 1.5 i 0.8, respectively. These data suggest that the two gender groups were similar for age, onset age, disease duration, and severity of dementia. When regional metabolic activity in these two groups was examined, none of the lateral association cortices, cingulate cortices, or medial temporal cortex showed statistically significant differences (two-sample Student's t test). We therefore pooled the two groups in the further analyses.
With data sets of 66 patients with probable Alzheimer's disease, regression analysis was performed to predict the metabolic pattern of very early Alzheimer's disease. For each extracted cortical pixel, linear regression was calculated using metabolic activities and MMSE scores for the 66 patients. Predicted metabolic activity at an MMSE score of 30 was then extrapolated based on an estimated regression line, resulting in a three-dimensional metabolic pattern of very early Alzheimer's disease. In addition, metabolic patterns at MMSE scores of 20, 10, and 0 were generated to examine progression of the disease. Note that the pattern at an MMSE score of 30 was extrapolated from patient data of MMSE scores 0 to 23 to represent a hypothetical metabolic pattern of very early Alzheimer's disease, and did not indicate a metabolic pattern in actual patients with an MMSE score of 30. These patterns were compared to those in 22 normal subjects using pixel-by-pixel Z-score analysis ([normal mean -predicted value]/normal standard deviation). By using Z-score analysis, the magnitude of metabolic reduction across areas with different baseline (normal) metabolic activity could be compared. Peak metabolic reduction in the predicted very early Alzheimer's disease was determined stereotactically.
The metabolic pattern of very early Alzheimer's disease was confirmed further using data sets obtained from 8 patients with only memory impairment who were diagnosed later as having probable Alzheimer's disease. The extracted cortical activity of these patients was compared to that of 22 normal subjects using a two-sample Student's t test on a pixel-by-pixel basis. Calculated t values were converted to Z values using a probability integral transformation for comparison with the above regression analysis. A statistical significance threshold for p = 0.05 was calculated on the 3D-SSP Z map using a "unified" formula which controls multiple pixel comparison and a shape of the stochastic process on the 3D-SSP format [25] . Regional metabolic reduction in this patient group was determined stereotactically in three dimensions.
To examine individual data in patients with very early Alzheimer's disease, region-of-interest analysis was performed in addition to the above pixel-by-pixel analysis. Five regions of interest were predefined stereotactically for each hemisphere based on the definition in the stereotactic brain atlas [23] as follows: parietal association cortex including Brodmann's cortical areas 5, 7, 39, and 40; temporal association cortex including areas 21, 22, 37, and 38; frontal association cortex including areas 6, 8, 9, 10, 11, 44, 45, 46, and 47; parahippocampal gyrus including areas 27, 28, and 34; and posterior cingulate cortex including areas 23 and 31. Although these cytoarchitectural areas cannot be appreciated directly on PET images, we use this numbering system to describe objectively regions included in the analysis. In addition, two regions of interest were obtained as a reference: anterior cingulate cortex including areas 24 and 32 and primary visual cortex including area 17. The extracted cortical activity was averaged within these regions. Since hemispheric asymmetry in metabolic alteration may exist in Alzheimer's disease [3], hemispheres were analyzed independently. Each regional value for a patient was compared to a corresponding mean value of 22 normal subjects on a region-by-region basis, and the magnitude of metabolic reduction was expressed as a Z score. A Student's t test was used to assess differences in region-of-interest values between normal subjects and patients with very early Alzheimer's disease. A Wilcoxon signed rank test was used to assess differences in the magnitude of metabolic reduction between the posterior cingulate cortex and other regions.
Results
In normal subjects, there was intense energy metabolic activity in the posterior cingulate cortex and cinguloparietal transitional area (Fig 1) . Metabolic [23] . Peak x coordinates of the posterior cingulate cortex and cinguloparietal transitional area were projected to the midsagittal plane ( x = 0).
Fig 3. Cerebral metabolic activig in patients with very early Alzbeimeri disease (Early AD) in comparison to that of normal controls (N, identical to N in Fig 1). Two group-averaged images were compared using c statistics and converted to Z images (Z). Images represent right hteral (RT.LAT), l e j hteral (LT.LAT), right medial (RT.MED), and left medial (LT.MED) views of the brain. Metabolic reduction in the posterior cinguhte cortex and the cinguloparietal area is demonstrated clearly on both groupaveraged images (Early AD) and Z images (Z). Rehtively mild but definite metabolic reduction in the parietal and temporal association cortices was also evident in very early Alzheimeri disease. Note the consistency of these results with the predicted pattern of very early Alzheimeri disease (see Fig 2).
at an MMSE score of 30, which was extrapolated from data sets of MMSE scores of 0 to 23, revealed the disappearance of such intense metabolic activity in the posterior cingulate cortex (see Fig 1) . Predicted metabolic activity in the parietal and temporal association cortices showed only mild reduction at this stage. Areas of predicted metabolic reduction were clearly demonstrated on 2-score maps (Fig 2) , and peaks of metabolic reduction were localized stereotactically (Table) . Focally accentuated metabolic reduction in the posterior cingulate cortex was evident bilaterally. As the disease progresses, metabolic reduction in the lateral neocortex becomes more apparent. At MMSE scores of 10 and 0, there is metabolic reduction involving nearly the entire association cortex but sparing relatively the primary sensorimotor cortex, primary visual cortex, and cerebellum (Figs 1, 2) . This pattern is consistent with a well-known metabolic feature of Alzheimer's disease.
The metabolic pattern actually observed in patients with very early Alzheimer's disease is mostly consistent with the above-described predicted pattern. In these patients with very early Alzheimer's disease, there was significant metabolic reduction in the posterior cingulate cortex extending to the cinguloparietal transitional area (Fig 3 ) . Peak metabolic reduction was in close agreement with the predicted result (see Table) When patients with very early Alzheimer's disease were examined individually, metabolic reduction in the posterior cingulate cortex was significantly greater than that in the other cortical regions (Fig 4) . In comparison to parietal, temporal, and frontal association cortices, the greater metabolic reduction in the posterior cingulate cortex was significant at p = 0.070, 0.049, and 0.004, respectively (Wilcoxon test, two-tailed probability using normal approximation). Although the posterior cingulate cortex showed the greatest metabolic reduction, mild metabolic reduction in the parietal and temporal cortices also existed in very early Alzheimer's disease (see Figs 3, 4) . The metabolic reduction in the posterior cingulate cortex was also significantly greater than that of the parahippocampal cortex ( p = 0.015). vealed no neuronal loss in the posterior cingulate cortex, although as the authors discussed, the removal of cortical afferents could have indirectly caused increasing neuron density. The topographical distribution of neurofibrillary tangles is not necessarily more severe in the posterior cingulate cortex compared to the medial and inferior temporal cortex [28] . Pathological examination of presumably very early Alzheimer's disease [29] revealed extensive neurofibrillary tangle formation only in the medial and inferior temporal cortex, but not in the posterior cingulate cortex. This pathological evidence summarizes the presence of significant neurodegeneration in the posterior cingulate cortex, which, however, may not be the most consistent structural change in very early Alzheimer's disease. The discordance between our current findings of very early metabolic reduction in the posterior cingulate cortex and the pathological evidence raises the possibility of functionally, but not structurally altered neuroiial circuits in the posterior cingulate cortex. Simonian and Hyman [30] demonstrated the absence of correlation between structural pathology and functional activity of neurons measured by cytochrome oxidase activity, suggesting that functional alteration may precede or disagree with structural abnormality in Alzheimer's disease. In addition, reduced cytochrome oxidase activity occurs experimentally following deafferentation of neuronal circuits [31] due to a decrease in neuronal firing and Na/K ATPase activity [32] . Deoxyglucose uptake is known to correlate with neuronal activity, particularly at synapses instead of perikarya [33] , and to coincide with cytochrome oxidase staining [34] . Therefore, our findings of very early metabolic reduction in the posterior cin-gulate cortex could be explained by very early functional or structural deafferentation, or both, caused by primary neural degeneration in the other parts of the brain in addition to subsequent or simultaneous primary degeneration in the posterior cingulate cortex.
Discussion
As indicated by deafferentation, neural connection seems to play an important role in the development of Alzheimer's pathology [35] . Parts of the brain affected in Alzheimer's disease are tightly interconnected. In light of connectivity, the posterior cingulate cortex has various connections with other limbic structures as well as association cortices. These connections and the cortical cytoarchitecture of the posterior cingulate cortex are distinct from those of the anterior cingulate cortex [36] . Afferent pathways to the posterior cingulate cortex studied in monkeys [36] [29, 38, 391 . In contrast to entorhinal cortex layer 11, which forms the perforant pathway to the hippocampal formation, layer IV of the entorhinal and posterior parahippocampal cortices gives widespread projections to sensory-specific and multimodal association cortices . In Alzheimer's disease, it is reported that layers I1 and IV are affected severely compared to other layers [43] .
The severe metabolic reduction in the posterior cingulate cortex coincides with previous observations of neuronal degeneration in the posterior cingulate/ retrosplenial cortex induced by N-methyl-D-aspartate (NMDA) antagonists such as phencyclidine, MK-801, and ketamine [44, 451 . The mechanism is attributed to the abolishment of gamma-aminobutyric acid (GABA) inhibition, which is maintained by tonic glutamatergic input, and thus major glutamatergic and cholinergic inputs to cortical neurons induce excitotoxicity [46] .
Since systemically administered NMDA antagonists act globally, the posterior cingulate cortex seems to be the structure that demonstrates the initial evidence of global deterioration of the glutamatergic neuronal transmission. Despite difficulties in determining the glutamatergic neurotransmitter system in the brain, there is accumulating evidence that corticocortical fibers of pyramidal neurons are glutamatergic [47, 481, and those glutamatergic neurons are degenerating substantially in Alzheimer's disease [49- 521. Considering the above-cited evidence, the early metabolic reduction in the posterior cingulate cortex observed in the current study may be a consequence of global derangement of cortical glutamatergic neurons which interconnect the posterior cingulate cortex and other cortical structures, including the entorhinal cortex, as discussed previously. In fact, the parietal and temporal association cortices had a relatively mild but not negligible metabolic reduction in patients with very early Alzheimer's disease (see Fig 3) .
A somewhat puzzling result is the relatively mild metabolic reduction in the parahippocampal cortex. This result is in agreement with previous observations using an ultra-high-resolution PET scanner [ 531 and ["C]deoxyglucose [13] . A technical problem in measuring metabolic activity in a relatively small area of the medial and inferior temporal lobe is always a concern. Using exactly the same analytical technique, however, we previously demonstrated severe metabolic reduction in the medial temporal lobe in patients with progressive limbic sclerosis [54] . The presence of atrophy affects PET measurement of regional metabolic activity owing to partial volume effects, but in a way metabolic activity appears more decreased instead of relatively preserved. When a presynaptic terminal density in Alzheimer's disease was examined, the most severe loss was found in the frontal and parietal cortices, not in the entorhinal cortex or hippocampus [55] . Synaptic density in entorhinal cortex layers I11 and V was reported to be preserved [56] . Since deoxyglucose uptake correlates with synaptic activity [33] , relatively mild energy metabolic reduction in the parahippocampal cortex seems to be in agreement with the structural observations. A relatively mild reduction in synaptic activity in contrast to the severe neuronal degeneration in the medial temporal lobe could be, at least in part, attributable to synaptic plasticity. Following an experimental lesion in the entorhinal cortex, synaptic regeneration in the dentate gyrus was suggested [57] . There is morphological evidence that the remaining synapses in the dentate gyrus of Alzheimer's disease patients show an increase in synaptic junctional area [58] . Furthermore, after loss of entorhinal neurons in Alzheimer's disease, cholinergic and commissural associational sprouting seems to take place in the hippocampal formation [59, 601 . The relationship among synaptic plasticity and regional energy metabolism, however, needs to be investigated further in patients with Alzheimer's disease. Neuropsychological studies suggest the role of the posterior cingulate cortex in spatial learning and memory in monkeys [61] ; in acquisition and long-term memory processes in rats [62] ; in learning and memory deficits in mice due to posterior, but not anterior, cingulate lesions [63] ; in spatial orientation and memory in rats and monkeys [64] ; and in verbal and auditory memory in monkeys [65] . In addition, the retrosplenial cortex is involved in anterograde and retrograde amnesia in humans [66] and visual tracking tasks with a delay in monkeys [67] , although some of these observations may be attributable in part to injury to the cingulum [68] . As indicated in the current study, early metabolic reduction in the posterior cingulate cortex is associated with severe learning and memory impairment without general cognitive decline. Comparisons between metabolic alterations in the posterior cingulate cortex and detailed neuropsychological test results are subject to further investigations.
In our previous report of normal subjects and multiinfarct patients, we did not observe metabolic abnor- 
